Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Based on

1 Articles
2016 Most recent source

Composition

1

1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate)

DCPE-modified poly(ATU-IPDI) DCPE-PU-DCPE
Type Polymer
Formula
Role carriers
2

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material

Properties

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Method 2

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Method 3

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Method 4

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial